Research statistics
Noopept research: publications and trials
At a glance
Publications, all years
85
Since 1997
Publications in 2026 so far
0
Through November 8, 2026
Human clinical research
10.7%
9 of 84 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
0
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
83.3%
63 animal · 7 in vitro · 0 computational
Records that only mention it
21
Not counted above
Status in the library: Research only. Groups: Cognitive and neurological peptides. 1 publications are not yet classified by study type.
What to keep in mind
- Fewer than three randomized controlled trials are indexed.
- More than 70% of the indexed publications are animal, cell or computational studies.
- Not a peptide: it is shown for completeness and left out of every peptide total.
Publications by year
Noopept publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1997 | 0 | 5 | 0 | 0 | 5 |
| 1998 | 0 | 2 | 0 | 0 | 2 |
| 1999 | 0 | 1 | 0 | 0 | 1 |
| 2000 | 0 | 3 | 0 | 0 | 3 |
| 2001 | 0 | 2 | 0 | 0 | 2 |
| 2002 | 0 | 6 | 1 | 0 | 7 |
| 2003 | 0 | 3 | 1 | 0 | 4 |
| 2004 | 1 | 1 | 0 | 0 | 2 |
| 2005 | 0 | 3 | 0 | 0 | 3 |
| 2006 | 0 | 3 | 0 | 0 | 3 |
| 2007 | 1 | 5 | 0 | 0 | 6 |
| 2008 | 3 | 4 | 0 | 0 | 7 |
| 2009 | 2 | 2 | 0 | 1 | 5 |
| 2010 | 0 | 3 | 0 | 0 | 3 |
| 2011 | 1 | 3 | 1 | 0 | 5 |
| 2012 | 0 | 3 | 0 | 0 | 3 |
| 2013 | 0 | 1 | 0 | 0 | 1 |
| 2014 | 0 | 4 | 0 | 0 | 4 |
| 2015 | 0 | 1 | 0 | 0 | 1 |
| 2016 | 0 | 2 | 0 | 0 | 2 |
| 2018 | 1 | 2 | 1 | 0 | 4 |
| 2019 | 0 | 4 | 0 | 0 | 4 |
| 2020 | 0 | 1 | 0 | 0 | 1 |
| 2021 | 0 | 2 | 0 | 1 | 3 |
| 2022 | 0 | 2 | 0 | 0 | 2 |
| 2023 | 0 | 1 | 0 | 0 | 1 |
| 2024 | 0 | 1 | 0 | 0 | 1 |
Study types
| Animal study | 63 |
|---|---|
| Other clinical trial | 7 |
| In vitro study | 7 |
| Review | 4 |
| Observational human study | 2 |
| Editorial, letter or other | 1 |
| Not yet classified | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Cognitive health | 58 |
|---|---|
| Neurological and mental health | 49 |
| Metabolic health | 9 |
| Cardiovascular | 8 |
| Endocrinology | 8 |
| Immune system | 3 |
| Musculoskeletal | 3 |
| Tissue repair | 3 |
| Antimicrobial and infectious disease | 1 |
| Oncology | 1 |
| Reproductive and sexual health | 1 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- [The influence of self-massage combined with drug Noopept on the professional performance of teachers older.]
Advances in gerontology = Uspekhi gerontologii · January 1, 2018 · Other clinical trial · cited 0 times
PMID 30877834 · Human clinical research
- [Noopept in the treatment of mild cognitive impairment in patients with stroke].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2011 · Other clinical trial · cited 1 times
PMID 22500312 · Human clinical research
- Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
Neuroscience and behavioral physiology · March 1, 2009 · Other clinical trial · cited 17 times
PMID 19234797 · DOI 10.1007/s11055-009-9128-4 · Human clinical research
- [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2008 · Other clinical trial · cited 0 times
PMID 18697252 · Human clinical research
- [Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · January 1, 2008 · Other clinical trial · cited 2 times
PMID 19008801 · Human clinical research
- [Meteoadaptogenic properties of peptide drugs in healthy volunteers].
Eksperimental'naia i klinicheskaia farmakologiia · November 1, 2007 · Other clinical trial · cited 2 times
PMID 18318195 · Human clinical research
- [Interspecies differences of noopept pharmacokinetics].
Eksperimental'naia i klinicheskaia farmakologiia · January 1, 2004 · Other clinical trial · cited 2 times
PMID 15079908 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · May 1, 2003 · In vitro study · cited 65 times
PMID 12711349 · DOI 10.1016/s0736-5748(03)00031-5 · In vitro studies
- The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
Journal of psychopharmacology (Oxford, England) · November 8, 2006 · Animal study · cited 50 times
PMID 17092975 · DOI 10.1177/0269881106071335 · Animal studies
- Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model.
Behavioural pharmacology · September 1, 1999 · Animal study · cited 36 times
PMID 10780261 · DOI 10.1097/00008877-199909000-00013 · Animal studies
- Five Unapproved Drugs Found in Cognitive Enhancement Supplements.
Neurology. Clinical practice · June 1, 2021 · Editorial, letter or other · cited 35 times · open access
PMID 34484905 · DOI 10.1212/cpj.0000000000000960 · Commentary and other
- The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine.
European journal of drug metabolism and pharmacokinetics · July 1, 1997 · Animal study · cited 30 times
PMID 9358206 · DOI 10.1007/bf03189814 · Animal studies
Latest publications
- Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) - An active pharmaceutical ingredient with nootropic activity.
Journal of pharmaceutical and biomedical analysis · September 16, 2024 · In vitro study · cited 0 times · open access
PMID 39298839 · DOI 10.1016/j.jpba.2024.116474 · In vitro studies
- Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats.
Biotechnic & histochemistry : official publication of the Biological Stain Commission · March 22, 2023 · Animal study · cited 6 times
PMID 36946173 · DOI 10.1080/10520295.2023.2187460 · Animal studies
- Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats.
International journal of molecular sciences · December 30, 2022 · Animal study · cited 9 times · open access
PMID 36614135 · DOI 10.3390/ijms24010690 · Animal studies
- Effect of nootropic dipeptide noopept on CA1 pyramidal neurons involves α7AChRs on interneurons in hippocampal slices from rat.
Neuroscience letters · October 3, 2022 · Animal study · cited 0 times
PMID 36195298 · DOI 10.1016/j.neulet.2022.136898 · Animal studies
- Noopept Attenuates Diabetes-Mediated Neuropathic Pain and Oxidative Hippocampal Neurotoxicity via Inhibition of TRPV1 Channel in Rats.
Molecular neurobiology · July 9, 2021 · Animal study · cited 30 times
PMID 34241806 · DOI 10.1007/s12035-021-02478-8 · Animal studies
- QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · June 11, 2021 · Animal study · cited 18 times
PMID 34126240 · DOI 10.1016/j.ejps.2021.105909 · Animal studies
- Five Unapproved Drugs Found in Cognitive Enhancement Supplements.
Neurology. Clinical practice · June 1, 2021 · Editorial, letter or other · cited 35 times · open access
PMID 34484905 · DOI 10.1212/cpj.0000000000000960 · Commentary and other
- Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.
Doklady. Biochemistry and biophysics · September 1, 2020 · In vitro study · cited 13 times
PMID 33119829 · DOI 10.1134/s1607672920050129 · In vitro studies
- Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.
Bulletin of experimental biology and medicine · November 27, 2019 · Animal study · cited 3 times
PMID 31776952 · DOI 10.1007/s10517-019-04681-z · Animal studies
- MANAGEMENT OF AMNESTIC AND BEHAVIORAL DISORDERS AFTER KETAMINE ANESTHESIA.
Georgian medical news · September 1, 2019 · Animal study · cited 4 times
PMID 31687967 · Animal studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: GVS-111; N-phenylacetyl-L-prolylglycine ethyl ester; Noopept; Omberacetam
((TITLE_ABS:"GVS-111" OR CHEM:"GVS-111" OR TITLE_ABS:"GVS111" OR CHEM:"GVS111") OR (TITLE_ABS:"N-phenylacetyl-L-prolylglycine ethyl ester" OR CHEM:"N-phenylacetyl-L-prolylglycine ethyl ester") OR (TITLE_ABS:"Noopept" OR CHEM:"Noopept") OR (TITLE_ABS:"Omberacetam" OR CHEM:"Omberacetam")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 9). Noopept research statistics (Version weekly-2026-11-08) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/noopept